Clinical and genetic findings of five patients with WT1-related disorders

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 8, 2008, Pages 1236-1243

  De Andrade, Juliana Gabriel R ^a   Guaragna, Mara Sanches ^a   Soardi, Fernanda Caroline ^a   Guerra Jr , Gil ^a   De Mello, Maricilda Palandi ^a   Andréa, Trevas Maciel Guerra ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Denys Drash syndrome; Frasier syndrome; Sex differentiation; WAGR syndrome; WT1 gene

Indexed keywords

EID: 58849100835     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302008000800006     Document Type: Article

References (29)

1. Luo X, Ikeda, Y, Parker, KL A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell. 1994;77:481-90.
2. Swain A, Zanaria E, Hacker A, Lovell-Badge R, Camerino G. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nature Genet. 1996;12:404-9.
3. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, et al. The candidate Wilms'tumour gene is involved in genitourinary development. Nature. 1990;346: 194-7.
4. Rose EA. Glaser T, Jones C, Smith CL, Lewis WH, Call, KM, et al. Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumour gene. Cell. 1990;60:405-508.
5. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms'tumour locus. Cell. 1990;60:509-20.
6. Gessler M, Konig A, Bruns GAR Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990;343:774-8.
7. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, et al. The candidate Wilms'tumour gene is involved in genitourinary development. Nature. 1990;346: 194-7.
8. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms tumour gene WT1. Proc Nat Acad Sci. 1991;88:9618-22.
9. Laity JH, Chung J, Dyson HJ, Wright PE. Alternative splicing of Wilms' tumour suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes. Biochemistry. 2000;39:5341-8.
10. Hossain A, Saunders GF. The human sex-determining gene SRY is a direct target of WT1. J Biol Chem. 2001;276:16817-23.
11. Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA. Wilms' tumour 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell. 1998;93:445-54.
12. Moffett P, Bruening W, Nakagama H, Bardeesy N, Housman D, Housman DE, Pelletier J. Antagonism of WT1 activity by protein self-association. Proc Natl Acad Sci USA. 1995;92:11105-9.
13. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991;67(2):437-47.
14. Patek CE, Little MH, Fleming S, Miles C, Charlieu JP, Clarke AR, et al. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Proc Natl Acad Sci USA. 1999;96(6):2931-6.
15. Barbaux S, Niaudet P, Gubler M-C, Grunfeld J-P, Jaubert F, Kuttenn F, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nature Genet. 1997;17:467-70.
16. Klamt B, Koziell A, Poulat F, Wieacker P, Scambler P, Berta P, Gessler M. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Hum Mol Genet. 1998;7(4):709-14.
17. Miller RW, Fraumeni Jr. JF, Manning MD. Association of Wilms' tumour with aniridia, hemihypertrophy and other congenital malformations. New Eng J Med. 1964;270:922-7.
18. Schmickel RD. Chromosomal deletions and enzyme deficiencies. J Pediat. 1986;108:244-6.
19. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990;343: 774-8.
20. Sambrook J, Fritsch EF, Maniatis TE. Molecular cloning, a laboratory manual. Cold Spring Harbor, New York. 1989.
21. Tagliarini EB, Assumpção JG, Scolfaro MR, Mello MP, Maciel-Guerra AT, Guerra Junior G, et al. Mutations in SRY and WT1 genes required for gonadal development are not responsible for XY partial gonadal dysgenesis. Braz J Med Biol Res. 2005;38(1):17-25.
22. Verp MS, Simpson JL. Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet. 1987;25:191-218.
23. Hoepffner W, Horn LC, Simon E, Sauerbrei G, Schröder H, Thamm-Mücke B, et al. Gonadoblastoma in 5 patients with 46, XY gonadal dysgenesis. Exp Clin Endocrinol Diabetes. 2005;113(4):231-5.
24. Hingorani M, Moore A. Aniridia. In: GeneReviews at Gene-Tests: Medical Genetics Information Resource (database on the internet). Seattle: University of Washington, 2002 [Updated 2008 July 12; cited 2008 August 19]. Available from: http://www.genetests.org.
25. Melo KF, Martin RM, Costa EM, Carvalho FM, Jorge AA, Arnhold IJ, et al. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis. J Clin Endocrinol Metab. 2002;87(6):2500-5.
26. Köhler B, Pienkowski C, Audran F, Delsol M, Tauber M, Paris F, et al. An N-terminal WT1 mutation (P181S) in an XY patient with ambiguous genitalia, normal testosterone production, absence of kidney disease and associated heart defect: enlarging the phenotypic spectrum of WT1 defects. Eur J Endocrinol. 2004;150(6):825-30.
27. Cho HY, Lee JH, Choi HJ, Lee BH, Ha IS, Choir Y, et al. WT1 and NPHS2 mutations in Korean children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2008;23(1):63-70.
28. Gbadegesin R, Hinkes B, Vlangos C, Mucha B, Liu J, Hopcian J, et al. Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2007;22(4):509-13.
29. Little M, Wells C. A clinical overview of WT1 gene mutations. Hum Mutat. 1997;9(3):209-25.